Skip to main content

Table 4 Estimated Distribution of varicella costs (€) in Europe by age group and health care resource in absence of UVV

From: Economic burden of varicella in Europe in the absence of universal varicella vaccination

Age group Primary care visits Hospitalizations Prescriptions OTC medications Work loss caregivers Work loss patients Work loss deaths Proportion of total cost
<5y € 51,939,569 € 29,121,301 € 18,648,121 € 20,541,844 € 193,314,712 NA NA 47.32%
5-9y € 30,605,288 € 8,138,576 € 10,516,603 € 11,741,757 € 105,800,000 NA NA 25.17%
10-14y € 7,830,211 € 2,117,755 € 2,853,437 € 826,043 € 24,659,029 NA NA 5.78%
15-19y € 2,936,218 € 1,940,903 € 1,071,301 € 585,661 € 8,938,000 NA NA 2.34%
20-39y € 7,259,423 € 9,407,695 € 2,517,461 € 1,362,976 NA € 75,435,180 € 57,955 14.49%
40-64y € 2,413,798 € 3,123,022 € 961,981 € 615,262 NA € 25,146,631 € 164,349 4.89%
Total € 102,984,507 € 53,849,251 € 36,568,905 € 35,673,544 € 332,711,741 € 100,581,811 € 222,303 100.00%